Digital Health

Trend Analysis: AI-Driven Coverage Decisions
Technology Trend Analysis: AI-Driven Coverage Decisions

The digital revolution in healthcare has delivered algorithms designed to predict recovery with statistical precision, yet these same tools are increasingly blamed for denying necessary care to vulnerable patients. As artificial intelligence becomes more integrated into the administrative fabric of

How Is AI Rewriting Pharma's Rules of Engagement?
Technology How Is AI Rewriting Pharma's Rules of Engagement?

From Fragmented Tools to Intelligent Orchestration Human relationships are and always will be the crux of meaningful customer engagements in the pharmaceutical industry. No channel rivals the impact of a well-prepared, well-supported representative, especially when considering that research shows

What If Medicare Paid for Wellness Instead of Sickness?
Technology What If Medicare Paid for Wellness Instead of Sickness?

The United States healthcare system operates on a staggering paradox, where the overwhelming majority of its multi-trillion-dollar expenditure is dedicated not to preserving health but to managing diseases that could have been prevented. For decades, the national conversation has orbited around

Why Strategic Marketing Is Vital for Healthcare
Business Why Strategic Marketing Is Vital for Healthcare

The once-clear line separating clinical practice from business strategy has effectively dissolved, compelling medical institutions to recognize that the journey to patient care no longer begins with a referral slip but with a search query. In an environment where patients are empowered consumers

How Can Virtual Care Stop Patient Leakage?
Technology How Can Virtual Care Stop Patient Leakage?

In an era where convenience often dictates consumer choice, traditional health systems are facing a critical challenge: retaining patients who are increasingly drawn to the accessibility of retail clinics and standalone digital health apps. This shift not only fragments patient care but also

Obesity Deals Soar as Biopharma Funding Dips
Technology Obesity Deals Soar as Biopharma Funding Dips

A Tale of Two Markets: Biopharma's Bifurcated Landscape in 2025 The biopharmaceutical industry entered 2026 having navigated a year of sharp contrasts, a dynamic laid bare by year-end industry analysis. While a palpable chill settled over venture capital and public markets, a feverish gold

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later